Sphere Medical Share Discussion Threads

[del44] 22/5/2017 14:35

14p here we come so...who needs twitter....LOL....

[cc2014] 22/5/2017 13:52

Starting to rock and roll Del. Looks like a inverted head and shoulders if you are into that sort of stuff

[del44] 22/5/2017 13:45

We are now trading at our ceiling for some time......
But some nice buying this morning/afternoon so far....

[cc2014] 21/5/2017 15:26

Interesting MM action
02/05 Bid/Offer 6.12-6.59 Start of day RNS
02/05 ?-7.37 End of day
03/05 6.63-7.22
04/05 7.12-7.75
05/05 7.16-7.75
08/05 7.00-7.28
10/05 6.67-7.28 Price stabilizes
12/05 6.71-7.40
15/05 6.72-7.40
16/05 6.71-7.28
17/05 6.90-7.40
18/05 6.95-7.40
19/05 6.95-7.45 Price creeping up as MM have to offer improved bid to encourage sellers as their appetite to sell stock below 7.50 diminishes

[cc2014] 19/5/2017 08:51

hmm - solid support on the bid side with the MM's happy to buy stock in volume within the spread. Some stock left available to buy at 7.4 but not that much.

It would be lovely to see a few buys putting pressure on the share price to the upside. Fingers crossed.

[cc2014] 16/5/2017 13:39

Someone collecting stock?

[cc2014] 06/5/2017 14:32

So, here is the spreadsheet I put together a couple of months ago. As time has come to pass I guessed we would have 4 customers by now, instead we have 6. It will be interesting to see where we are by the end of June as that will give up some idea about how fast the snowball is starting to gather pace.

The income per hospital whilst matching with Sphere estimate from their presentation I suspect may be too high. On the other hand if paeds takes off as we suspect it might the figure may be easily achievable. A typical adult patient in ICU would only need 1 sensor as stabilization will take place within 72 hours. I don't know this for sure but I would assume paeds patients may be monitored for a far longer period of time resulting in far more sensor sales.

[del44] 05/5/2017 22:19

Calibration fluid, flush bags and device comes in around £200.....the monitor is usually rented.....something along those lines....
Revenue is minuscule at the moment...but sales are beginning to get some sort of traction.

[jamesd888] 05/5/2017 15:07

£30,000 is this correct?. How much do they sell each item for?

[longshanks] 05/5/2017 14:59

Diddly squat

[jamesd888] 05/5/2017 10:55

What was the revenue generated for this company last year?

[del44] 04/5/2017 18:24

Nice 130,000 buy at full ask in auction!!!

[cc2014] 02/5/2017 19:41

An interesting RNS which may mark something substantial when we look back in a years time.

14 hospital valuations lead to 6 orders so far (with talks continuing on an unknown number of the remaining 8). I find this a pretty high conversion rate and gives me comfort there is a real market for the product. The paeds take up is interesting and this is where I think we will say a very high conversion rate. I work in the NHS and it's hard to say no to anything that improves care for children.

I think we are on our way now. I perceive it's much easier for their salesforce to sell to the 7th customer when they already have sold to 6 and so on. The management have clearly been holding back news rather than releasing bit by bit. Funny how a distributor in Austria is just tucked away. 6 months ago Sphere would have been shouting about it. How times have changed.

It will be interesting to see if any institutional interest arises over the next few weeks.

Nearly 500k buys today. I guess these are astute PI's who may or may not flip for a small profit. It will be interesting to see if there is any further coverage over the next few days.

[cinquepercento] 02/5/2017 13:13

Timbo003.

Your link with Trinity Research is a nice comprehensive,realistic evaluation of Sphere Medical.

I have not seen such detail on the Sphere Medical Website.

So it would seem that 2018 might be a good year.

Cinquepercento.

[pugugly] 02/5/2017 11:42

timbo003:_ Thanks for note - Looks to me as though they took 5 pages (although with more detail) that I took some 5 lines. All (imo of course !!!!!!!!!!!!!!!!!!!)

[timbo003] 02/5/2017 11:26

New Trinity Research note now available.

They estimate that Sphere will be looking to raise £7-8m this year

[cinquepercento] 02/5/2017 11:17

It seems that someone just bought 340,576 shares if trade figures here are to be believed.
What are we expecting to happen here, a quick jump to 13 pence or so followed by a quick profit-taking or sell off?
I am not buying any more unless it reaches support at over 15 pence.
I need 13 pence to break even.

Cinquepercento.

[cinquepercento] 02/5/2017 11:16

It seems that someone just bought 340,576 shares if trade figures here are to be believed.
What are we expecting to happen here, a quick jump to 13 pence or so followed by a quick profit-taking or sell off?

Cinquepercento.

[timbo003] 02/5/2017 09:01

>>>>>>cumnor, if you are waiting for a 2-3p placing to buy in, that is probably wishful thinking on your part.

Sphere certainly have a bit of breathing space for timing a fund raise with the Silicon Valley Bank loan now in place.

If the analyst's notes are to be believed, Sphere require a further £10m to reach breakeven, so a 2-3p placing implies that you would be able buy a company targeting $200m (plus) high margin sales for just £14m.

Incidentlty, I seem to recall hearing at one recent meeting that the paediatric usage has not been factored into the the last analyst numbers, so it will be interesting to read the latest Trinity Delta analysis when it appears.

[cumnor] 02/5/2017 08:37

A long way to go-would have expected big interest from some large medical device companies at this stage if product is a ground breaker. Imo being talked up for placing at 2-3P.
aimo

[cinquepercento] 02/5/2017 08:33

Re: above comments.

Longshanks: Re: news deliberately designed to increase the share price:

You are probably right but the share price could do with a good increase.

It seems that we are all agreed that Proxima 4 etc is a good product.

All that remains to do then,is to relentlessly push towards meaningful sales.

The price is cheap enough in my opinion to motivate the directors etc to buy into this product and help push the price up but without serious sales,the price will quickly drop back again as speculators take profits.

Of course,they would be tempted to quickly sell the shares for a quick profit before the price dropped back again.

The company seems to be making a genuine effort to sell the product but it is taking a long time for the sales to gather pace,a bit like watching paint dry.

Well,I will hold onto my shares to the end.

So many time have I pulled out of diving shares only to see them shoot up later.

Cinquepercento.

[pugugly] 02/5/2017 08:04

Enquiry to demonstration to evaluation to conversion to order seems low given that most of the hospitals should have been pre briefed and pre sold the benefits of Proxima 4. IMO the critical factor will be the running rate of usage in those who have bought after the novelty ?? as passed - In other words once Proxima4 has been bedded down in an ongoing environment will it become part of the regular patient monitoring programme -
Agree with both timbo and LS re balance sheet - at moment indications would be for a discounted placing

[longshanks] 02/5/2017 07:51

I wouldn't count on it. More likely that they will buy in a placing once they find someone willing to underwrite their own personal risk.

[timbo003] 02/5/2017 07:39

Yes, you could be right longshanks and a bit of director buying would definitely help at this stage to mop up any loose shares. I assume this trading statement now clears the decks if they decide to let the moths out of their wallets.